Skip to content
Home/Companies/MedTech/Nyxoah
Nyxoah

Nyxoah

MedTech·Belgium·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Nyxoah?

Nyxoah is a Belgian MedTech company, currently owned by Andera Partners since 2020.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Investor
Andera Partners
BioDiscovery 5 · 2017 · VC

Key facts

HQBelgium
SectorMedTech
Websitenyxoah.com

More from BioDiscovery 5

Other portfolio companies in the same fund.

Amolyt Pharma
Amolyt Pharma
Exited 2024
BiotechFrance· 2021
to AstraZeneca
Evommune
Evommune
Exited 2025
BiotechFrance· 2021
to Public market (NYSE IPO ticker EVMN)
AgoMab
AgoMab
Exited 2026
BiotechFrance· 2019
to Public market (Nasdaq IPO ticker AGMB)
AM Pharma
AM Pharma
Active
BiotechNetherlands· 2019
Arvelle
Exited 2021
BiotechSwitzerland· 2019
to Angelini Pharma
Exciva
Active
BiotechUS· 2019

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Nyxoah?

Nyxoah is currently owned by Andera Partners, through BioDiscovery 5, since 2020.

When did Andera Partners acquire Nyxoah?

Andera Partners acquired Nyxoah in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue